Razeghinejad R - Search Results

1

Fixed combination netarsudil-latanoprost for the treatment of glaucoma and ocular hypertension.

Sinha S, Lee D, Kolomeyer NN, Myers JS, Razeghinejad R. Sinha S, et al. Among authors: razeghinejad r. Expert Opin Pharmacother. 2020 Jan;21(1):39-45. doi: 10.1080/14656566.2019.1685499. Epub 2019 Oct 30. Expert Opin Pharmacother. 2020. PMID: 31663782 Review.

2

A Comparative Study of the Water Drinking Test in Eyes With Open-Angle Glaucoma and Prior Trabeculectomy or Tube Shunt.

Martinez P, Trubnik V, Leiby BE, Hegarty SE, Razeghinejad R, Savant S, Myers JS. Martinez P, et al. Among authors: razeghinejad r. J Glaucoma. 2017 Feb;26(2):119-125. doi: 10.1097/IJG.0000000000000589. J Glaucoma. 2017. PMID: 27875485

3

New glaucoma medications: latanoprostene bunod, netarsudil, and fixed combination netarsudil-latanoprost.

Mehran NA, Sinha S, Razeghinejad R. Mehran NA, et al. Among authors: razeghinejad r. Eye (Lond). 2020 Jan;34(1):72-88. doi: 10.1038/s41433-019-0671-0. Epub 2019 Nov 6. Eye (Lond). 2020. PMID: 31695162 Free PMC article. Review.

4

Pathophysiology and management of glaucoma and ocular hypertension related to trauma.

Razeghinejad R, Lin MM, Lee D, Katz LJ, Myers JS. Razeghinejad R, et al. Surv Ophthalmol. 2020 Sep-Oct;65(5):530-547. doi: 10.1016/j.survophthal.2020.02.003. Epub 2020 Feb 11. Surv Ophthalmol. 2020. PMID: 32057763 Review.

5

Fixed-combination topical anti-hypertensive ophthalmic agents.

Machen L, Razeghinejad R, Myers JS. Machen L, et al. Among authors: razeghinejad r. Expert Opin Pharmacother. 2020 Jul;21(10):1269-1282. doi: 10.1080/14656566.2020.1743264. Epub 2020 Mar 31. Expert Opin Pharmacother. 2020. PMID: 32228188 Review.

6

Ahmed Versus Baerveldt Glaucoma Drainage Device in Uveitic Glaucoma: A Retrospective Comparative Study.

Sinha S, Ganjei AY, McWatters Z, Lee D, Moster MR, Myers JS, Kolomeyer N, Mantravadi AV, Pro MJ, Razeghinejad R. Sinha S, et al. Among authors: razeghinejad r. J Glaucoma. 2020 Sep;29(9):750-755. doi: 10.1097/IJG.0000000000001583. J Glaucoma. 2020. PMID: 32590449

7

Current and new pharmacotherapeutic approaches for glaucoma.

Shalaby WS, Shankar V, Razeghinejad R, Katz LJ. Shalaby WS, et al. Among authors: razeghinejad r. Expert Opin Pharmacother. 2020 Nov;21(16):2027-2040. doi: 10.1080/14656566.2020.1795130. Epub 2020 Jul 27. Expert Opin Pharmacother. 2020. PMID: 32717157 Review.

8

Balancing treatments for patients with systemic hypertension and glaucoma.

Shukla AG, Razeghinejad R, Myers JS. Shukla AG, et al. Among authors: razeghinejad r. Expert Opin Pharmacother. 2020 Dec;21(18):2225-2230. doi: 10.1080/14656566.2020.1810235. Epub 2020 Aug 24. Expert Opin Pharmacother. 2020. PMID: 32835542 Review.

9

Preliminary Report on a Novel Virtual Reality Perimeter Compared With Standard Automated Perimetry.

Razeghinejad R, Gonzalez-Garcia A, Myers JS, Katz LJ. Razeghinejad R, et al. J Glaucoma. 2021 Jan 1;30(1):17-23. doi: 10.1097/IJG.0000000000001670. J Glaucoma. 2021. PMID: 32941320

10

Transscleral Cyclophotocoagulation for Glaucoma in the Setting of Uveal Melanoma.

Shukla AG, Vaidya S, Yaghy A, Razeghinejad R, Mantravadi AV, Myers JS, Kaliki S, Shields CL. Shukla AG, et al. Among authors: razeghinejad r. Ophthalmol Glaucoma. 2020 Sep 19:S2589-4196(20)30256-8. doi: 10.1016/j.ogla.2020.09.011. Online ahead of print. Ophthalmol Glaucoma. 2020. PMID: 32956897 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

54 results

Search Page